Many studies suggest a nasal spray vaccine to be more effective than the other mode of vaccination for Covid-19
This will provide patients a far more convenient, cost-effective treatment option in the country, Glenmark said in a regulatory filing.
Chris Miller, co-founder and Chief Science Officer, SaNOtize, shares updates about the product, its probable tie-ups with Indian companies and how the
Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age